Bivin & Associates, Inc. Cybin Inc. Call Options Transaction History
Bivin & Associates, Inc.
- $93.1 Million
- Q2 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYBN
# of Institutions
7Shares Held
54.4KCall Options Held
0Put Options Held
0-
Emfo, LLC24.5KShares$147,8290.01% of portfolio
-
Unique Wealth Strategies, LLC Burr Ridge, IL12.7KShares$76,6470.0% of portfolio
-
Covington Capital Management10KShares$60,4000.0% of portfolio
-
Kistler Tiffany Companies, LLC Berwyn, PA3.6KShares$21,7440.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.5KShares$15,1000.0% of portfolio
About CYBIN INC.
- Ticker CYBN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 166,120,000
- Market Cap $1B
- Description
- Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...